NCT01751555View on ClinicalTrials.gov

Efficacy and Safety of TDF+3TC+EFV in Adults With HIV/HBV Coinfection

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Hiv
Interventions
DRUG

Regimen:TDF+3TC+EFV

TDF+3TC+EFV for HIV/HBV co-infection

Trial Locations (1)

102206

National Center for AIDS/STD Control and Prevention, China CDC, Beijing

Sponsors

Collaborators (1)

Gilead Sciences
All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

National Center for AIDS/STD Control and Prevention, China CDC

OTHER_GOV